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Background: Diabetes Mellitus (DM) is associated with pathological changes in the central nervous system (CNS)
and alterations in oxidative stress. The aim of this study was to determine whether dietary supplement with whey
protein (WP) could improve neurobehavior, oxidative stress and neuronal structure in the CNS.
Methods: Animals were distributed in three groups, a control group (N), a diabetic mellitus group (DM) and a DM
group orally supplemented with WP (WP).
Results: The DM group of animals receiving WP had reduced blood glucose, significantly decreased free radical
Diphenyl-picrylhydrazyl (DPPH) and lower lipid peroxidation in brain tissue. The WP group of animals showed
improvement in balancing, coordination and fore-limb strength, oxidative stress and neuronal structure.
Conclusion: The results of this study show that dietary supplementation with WP reduced oxidative stress,
protected CNS neurons and improved the neurobehavior of diabetic mice.
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Diabetes Mellitus (DM) is regarded as a major global
epidemic of the 21stcentury [1]. DM is a complex and
heterogeneous metabolic disorder characterized by
hyperglycemia in several organs of affected individuals
[2]. DM is associated with decreased physical activities
brain atrophy and lesions [3].
Diabetic encephalopathy is characterized by impaired
cognitive functions and neurobehavior, neurochemical
changes and neuronal damage caused by the increased
intracellular glucose level. Previous studies assessed the
effect of chronic hyperglycemia on the function of neur-
onal mitochondria in the brain, the major site of reactive
free radical production in streptozotocin (STZ) diabetic
rats [4]. DM is characterized by disturbance in oxidative
stress that plays a central role in tissue damage. The* Correspondence: aallam@ksu.edu.sa
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unless otherwise stated.expression of reactive oxygen species (ROS), nitric oxide
and nitric oxide synthase were found to be increased in
mitochondria, whereas glutathione (GSH), peroxidase
activity and manganese superoxide dismutase were re-
duced in DM [5,6]. Also, GSH was reduced but glutathi-
one disulfide (GSSG) was increased in the brain of STZ
rats [4]. The overproduction of reactive species induced by
enhanced glucose oxidation might overwhelm the antioxi-
dant defenses, leading to cell damage. It has been reported
that normalizing mitochondrial superoxide production
blocks the pathways of hyperglycemic damage [7]. Re-
cently, however, the unique role of brain mitochondrial
dysfunction in experimental diabetes has been questioned
and it has been suggested that extra-mitochondrial factors
may be involved in the induction of oxidative stress in dia-
betes [8]. Emerging evidence showed that the increased
oxidative stress and consequent oxidative damage in hyper-
glycemic conditions begins in the mitochondria, the major
site of reactive oxygen species production [9].
The balance between oxidation and antioxidation and
is critical for maintaining a healthy biological system.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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ance in the homeostasis between oxidants and antioxi-
dants in the body. This imbalance leads to oxidative
stress in aging and various human diseases like athero-
sclerosis, stroke, diabetes, cancer and neurodegenerative
diseases such as Alzheimer disease and Parkinson dis-
ease [10]. The majority of oxidant species involved in
physiological oxidative events are anion superoxide (O−2),
hydroxyl radical (HO−), nitric oxide and peroxinitrite. In
stress conditions, these species can initiate further dele-
terious effects on biomolecules and cause cellular dam-
age. These effects can be lipid peroxidation [11], protein
oxidation [12], DNA damage [13], oxidation of the redu-
cing equivalents such as nicotinamides and thiols such
as GSH and alterations in intracellular calcium homeo-
stasis [14]. These phenomena can be prevented and/or
reversed, by the cellular antioxidant capacity; GSSG may
be converted to GSH through the enzymatic reaction
catalyzed by GSH reductase and NADPH [15]. Recent
accumulated evidence has shown that natural antioxi-
dants can prevent and treat the onset of diseases caused
and/or fostered by oxygen free radicals [16].
Diphenyl-picrylhydrazyl radical (DPPH) bleaching is one
of the strategies has been used to evaluate the antioxidant
properties of natural products; this method has shown to
be rapid and simple that measures the capacity of herbal
extracts and natural products to bleach the DPPH radical,
a nitrogen-centered free radical [17]. In foods, antioxi-
dants have been defined as substances that in small quan-
tity are able to prevent or greatly retard the oxidation of
materials such as fats [18]. However, biological antioxi-
dants have a further broad definition, which includes sys-
tems such as metal transport proteins (e.g. transferrin,
albumin, ferritin and ceruloplasmin) to prevent the redox
properties of metal, antioxidant enzymes and factors in-
volved in vascular homeostasis, signal transduction and
gene expression [19]. Thus, the cellular antioxidant mech-
anisms involve suppressing of ROS formation, reducing
oxygen free radicals (O−2, HO
− , ROO−) and H2O2, se-
questering metal ions, scavenging active free radicals,
repairing and/or clearing the oxidative damage. The bio-
activity of an antioxidant also depends on factors like its
physico-chemical characteristics and in vivo radical gener-
ating conditions [20].
Proteins are essential for the maintenance and repair
of body tissues. Camel whey protein (WP) is a heteroge-
neous group of proteins that include serum albumin, α
lactalbumin, immunoglobulin, lactophorin and peptido-
glycan recognition protein [21]. WP contains all of the
essential and nonessential amino acids and is a good
source of glutamine and the branched-chain amino acids
that are necessary for cell growth [22]. WP has been
found to significantly suppress hydroperoxide and ROS
levels in liver and other tissues in mice by stimulatingproduction of glutathione synthesis and cellular antioxi-
dant defense [23]. Therefore, WP may be used as a thera-
peutic tool for oxidative stress-associated diseases [24].
The purpose of the present study is to investigate the
effect of WP on oxidative metabolism in the brain,
examine neuronal structure and behavioral changes in
diabetic STZ Mice. Our hypothesis is that WP will pro-
tect neurons from oxidative stress in the brain which, in
turn, may leads to behavioral and morphological im-
provement in the brain of STZ mice.
Methods
Chemicals
Streptozotocin (STZ): (99% pure) and other chemicals
were purchased from Sigma chemical Company (St
Louis, MO, USA). All other chemicals used were of ana-
lytical grade.
Whey protein extraction
Camel milk was obtained from three breeds (Majaheem,
Maghateer and sofr) of camel from the Najd region in
Saudi Arabia. The milk was skimmed by centrifugation
at 5000 g for 20 min using a IEC Model K centrifuge,
[Boston, USA]. Skim milk was acidified to pH 4.3 using
1 M HCl. The precipitated casein was removed by cen-
trifugation, and the supernatant containing the whey
protein was brought to 70% saturation with ammonium
sulfate and incubated overnight at 4°C. The precipitate
containing whey proteins was collected by centrifugation
and dialyzed against distilled water for 48 h at 4°C using
a Spectra/Pro Membrane, MWCO 6000–8000 Da. The
obtained dialyzates were lyophilized using a Unitop
600SL, Virtis Company, Gardiner, New York, USA and
were kept at −20°C until used [25].
Mouse model of diabetes and investigations
This study did not involve endangered or protected ani-
mal species. All procedures were conducted in accord-
ance with the standards set forth in the guidelines for
the care and use of experimental animals by the Com-
mittee for the Purpose of Control and Supervision of Ex-
periments on Animals by the National Institutes of
Health, USA. The study protocol (care and handling of
experimental animals) was approved by the Animal Eth-
ics Committee of the Zoology Department in the College
of Science at King Saud University.
Adult albino male mice weighing 25–30 g, were obtained
from the College of Pharmacy, King Saud University, Saudi
Arabia and housed in stainless steel wire cages (2 animals/
cage) under pathogen-free conditions. The animals were
maintained at 18-22°C on a 12:12 h light/dark cycle and
provided with food and water ad libitum. The diabetic
group of animals were intraperitoneal injected with STZ
(70 mg/kg) to induce diabetes STZ-injected animals
Figure 1 Shows the blood glucose level in the normal group
(N), Diabetic group (DM) and whey protein treated group (WP).
Data are expressed as mean ± SED (N = 6; *p < 0.05, significantly
different from the normal group).
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days of injection. Diabetes was confirmed in Mice by
measuring the fasting blood glucose level (200–250 mg/
dl) before use. The animals were assigned into three
groups: 1) the first control group (N) was given phosphate
buffered saline, 2) the second DM group received STZ
(DM), 3) the third DM group was treated orally with whey
protein (WP) at a dose of 100 mg/kg/day for 5 days to in-
duce pre-diabetic condition and 21 days for post-diabetic
induction.
Biochemical, behavioral, and histological assays
Eight animals in each group were tested for behavioral
changes by using activity cage, rota-rod and grip
strength meter. After testing, animals were killed by de-
capitation. Blood samples were collected for glucose
assay, and brains were removed. Brain regions (cere-
brum, cerebellum and medulla oblongata) were dis-
sected, immediately cut into small pieces of 3 mm3 and
fixed in 10% buffered formalin pH 7.4 for 24 h. The tis-
sues were washed with buffered saline to remove excess
fixative and then dehydrated in ascending grades of ethyl
alcohol 70, 80, 90 and 95% for 45 min each and in two
changes of absolute ethyl alcohol for 30 min each. This
was followed by two changes of xylene for 30 min each.
The tissues were then impregnated with paraplast plus
(three changes) at 60°C for 3 h and then embedded in
paraplast plus. Sections (4–5 μm) were prepared with a
microtome, de-waxed, hydrated and stained in Mayer’s
hemalum solution for 3 min. The sections were stained
in eosin for 1 min, washed in tap water and dehydrated
in ethanol as described earlier. Hematoxylin–eosin-
stained sections were prepared [26].
For biochemical studies 0.25 g brain tissue was ho-
mogenized in 3 ml of cold saline. The homogenate was
centrifuged at 10,000 g for 10 min at 4°C, and the clear
supernatant was collected in a microfuge tube (0.5 ml
each) and stored at -40C until used.
Lipid peroxidation assay
Lipid peroxidation was determined by the reaction with
thiobarbituric acid. Malondialdehyde (MDA) formed was
determined according to the method of Preuss et al.
[27]. Briefly, 1.0 ml brain supernatant was precipitated
with 2 ml 7.5% trichloroacetic acid and centrifuged at
1,000 g for 10 min. Clear supernatant was mixed with 1
ml 0.70% thiobarbituric acid, incubated at 80 0C and the
absorbance measured at 532 nm. Tetramethoxypropane
was used as the standard.
DPPH assay
DPPH (2, 2-Diphenyl-1-Picryl Hydrazyl) is relatively
stable free radical. The assay was carried out essentially
by the method described by Joyeux et al. [28] andmodified by Viturro et al. [29]. The bleaching rate of DPPH
was monitored at 517 nm in the presence of the sample. In
its radical form, DPPH absorbs at 517 nm, but upon reduc-
tion by an antioxidant or radical species its absorption de-
creases. Briefly, tissue hydrolysate (1 ml) was added to a
methanolic solution of DPPH (75 μmol L − 1, 4 mL). The
mixture was shaken vigorously and left in the dark at room
temperature for 60 min, after which the absorbance was
measured at 517 nm. The DPPH-scavenging effect (%) was
calculated as [(absorbance at 517 control – absorbance at
517 sample)/OD517 control] × 100. α-tocopherol and BHT
were used as controls.
Cage activity test
The Ugo Basile 47420-Activity Cage was used to record
spontaneous co-ordinate activity in mice and variation
of this activity in time. This test was performed 3 min
for each animals.
Rota-rod assay
In this test, a mouse is placed on a horizontally oriented and
mechanically rotating rod at 15 rpm. The rod is suspended
above a cage floor, which is low enough not to injure the
animal, but high enough to induce avoidance of fall. Mice
naturally try to stay on the rotating rod, and avoid falling to
the ground. The length of time that a given animal stays on
this rotating rod is a measure of their balance, coordination,
physical condition, and motor-activity [30].
Grip-strength meter assay
The Ugo Basile 47200-Grip-Strength Meter suitable for
mice automatically measures grip-strength (i.e. peak force
and time resistance) of forelimbs in mice. The aim was to
assess forelimbs muscle strength. Each animal tested three
Figure 2 Shows the rota-rod records. (A), vertical and horizontal activities (B) and grip strength records for the fore-limb (C) in normal group
(N), diabetic group (DM) and whey protein treated group (WP). Data are expressed as mean ± S.D. (N = 6; *p < 0.05, significantly different from
the normal group).
Ajarem et al. Behavioral and Brain Functions  (2015) 11:7 Page 4 of 8times and the peak force of each mouse was recorded. The
mean of three values for each mouse was recorded.Glucose assay
Blood glucose levels were determined using the Accu-
Trend sensor (Roche Biochemicals, Mannheim, Germany).Figure 3 Shows the DPPH level. (A) and MAD level (B) in the brain tissu
group (WP). Data are expressed as mean ± SED (N = 6; *p < 0.05, significanStatistical analysis
The Statistical Package for the Social Sciences (SPSS for
windows version 11.0; SPSS Inc, Chicago) was used for
the statistical analyses. Comparative analyses were con-
ducted by using the general linear models procedure
(SPSS, Inc). Also, the data were analyzed using one-way
and two-way analysis of variance (ANOVA) followed bye of normal group (N), diabetic group (DM) and whey protein treated
tly different from the normal group).
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other. Results were expressed as mean ± S.D. The level
of significance was expressed as significant at P < 0.05
and highly significant at P < 0.01 [31].Results
Blood glucose level
The results showed that treatment of animals with
WP significantly decreased glucose level in DM mice
(Figure 1). The animals of WP group appeared more
active and healthy during the behavioral test.Figure 4 Sagittal sections in the cerebral cortex show the pyramidal c
(A, B) normal group. (C, D) diabetic group. (E, F) whey protein treated groBehavioral tests
In rotarod test, the WP treated mice stay on the rotating
rod longer than the DM mice (Figure 2A). Treatment of
mice with WP improved the balance, coordination, phys-
ical condition, and motor activity of the diabetic mice. In
the activity cage, the DM group animals appeared anxious
and recorded more scores in the horizontal and vertical
activities than the normal and WP group of animals
(Figure 2B). The WP group of animals showed signifi-
cant improvements in the grip strength scores and re-
corded stronger beak than the DM group of animals
(Figure 2C).ells distribution (PYN) and neurocyte chromatolysis (arrow).
up. (Hematoxylin and eosin stain).
Figure 5 Photographs of the cerebellar cortex show the
degenerated Purkinje cell (arrow), fissure (F), internal granular
layer (IGL), molecular layer (ML), Purkinje cell (PKC), Purkinje
cell layer (PCL), and white matter (WM). (A) normal group, (B)
diabetic group, (C) whey protein treated group. (Hematoxylin and
eosin stain).
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DPPH content was significantly increased (P < 0.001) in
DM group of animals. In WP-treated animals, the level
of DPPH was reduced to the level of DPPH in normal
animals (Figure 3A). WP treated mice showed insignifi-
cant (P > 0.05) increase in lipid peroxidation whereas a
significant increase in MDA (P < 0.001) was seen in DM
group (Figure 3B).
Brain histoarchitecture changes
The normal cells of the cerebral cortex had spherical or
pyramidal perikaryon whose nuclei were large with neurons
arranged in a regular pattern (Figures 4A &B). The cerebral
neurons appeared more developed toward the white matter
(Figure 4). Pathological changes were observed in many
sections in the DM group. Chromatolysis was observed in
DM groups and WP treated animals showed significant
neuronal protection. (Figures 4D & F).
In the cerebellum, the numbers of neurons in the
molecular layer of control mice (Figure 5A) were the
higher compared to diabetic and WP group of animals.
The control Purkinjee (PKC) cells were arranged in a
single row of large neurons with pear-shaped peri-
karyon and large nucleus (Figure 5A). The lateral pro-
cesses disappeared and the apical processes formed
the permanent dendritic tree (Figure 5). In DM group
(Figure 5B), some degenerated and pyknotic Purkinje
cells were detected and some were more spindle-
shaped and small (Figure 5C). The normal medulla
neurons appeared large in size, varied in shape and had
round nuclei (Figure 6A). In DM group, most of me-
dulla neurons appeared small and pyknotic (Figure 6B).
WP group medulla neurons showed improvement
(Figure 6C).
Discussion
The results of this study demonstrate that hyperglycemia
causes abnormalities in the neurobehavior of DM group
animals such as physical balance, coordination and grip
strength. Biochemical studies showed that DM is associ-
ated with disturbance in oxidative stress and neuronal
pathology. Neuronal death may lead to cognitive deficits
and an increased risk of brain complications [32]. In the
diabetic animals, several brain alterations have been de-
scribed, such as increased lipid peroxidation and DPPH
radicals, neuronal changes in the cerebrum, cerebellum
and medulla oblongata. Recently, a significant body of
evidence to indicate that diabetes has detrimental effects
on brain functions such as memory loss in type I and
type II diabetes [33]. Some investigators have also re-
ported a reduction in the length of the dendritic trees of
the Purkinjee cells and pyramidal cells in diabetic ro-
dents [34]. The diabetic animals show changes in den-
dritic morphology, probably associated with synapticdisturbances. This may explain memory and learning defi-
cits [3]. Oxidative stress is widely accepted as playing a
key mediatory role in the development and progression of
diabetes and its complications, due to the increased pro-
duction of free radicals and impaired antioxidant defenses
[35]. Several mechanisms can contribute to increased
Figure 6 Sagittal sections in the medulla oblongata show the
medulla neurons (MN). (A) normal group, (B) diabetic group,
(C) WP group. (Hematoxylin and eosin stain).
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posure to hyperglycemia. Accumulated evidence points
out that hyperglycemia can lead to elevated ROS and re-
active nitrogen species (RNS) production by the mito-
chondrial respiratory system [36], glucose autoxidation
[37], activation of the polyol pathway [38], formation of
advanced glycation end products [39], antioxidant enzyme
inactivation and an imbalance of glutathione redox status
[40]. Hyperglycemia can promote an important oxidative
imbalance, favoring the production of free radicals and the
reduction of antioxidant defenses. At high concentrations,
ROS/RNS can damage the major components of the cellu-
lar structure, including nucleic acids, proteins, amino
acids, and lipids [41]. Such oxidative modifications in thediabetes condition would affect several cell functions, me-
tabolism, and gene expression, which in turn can cause
other pathological conditions [42]. The oxidative stress
leads to neuronal damage in several brain regions [5]. For
example, neuronal loss in cerebrum impairs animal’s
memory [43], neuronal loss in cerebellum can have effect
on balance and coordination [6] and neuronal loss in me-
dulla oblongata and spinal cord can affect physical activity
of mice [44].
Supplementation with WP for 26 days decreased blood
glucose and showed significant improvement in the
physical balance, coordination, motor activities, and
muscles strength in diabetic animals. WP supplement
also decreased lipid peroxidation and DPPH radicals.
Overall, this study demonstrated that WP supplementa-
tion significantly improved pathological alterations in
diabetic mice as reported by Ebaid et al. [25]. WP has
been found to significantly suppress hydroperoxide and
ROS levels in liver and other tissues in mice by stimulat-
ing production of glutathione synthesis and thereby
boosting cellular antioxidant defense [23]. Therefore, we
suggest that WP may be an important therapeutic tool
to combat oxidative stress-associated diseases [24]. We
propose that WP may ameliorate diabetes in DM mice
by its ability to neutralize free radicals and thereby pre-
vent neuronal damage caused by oxidative stress.Conclusions
WP has a unique protective effect on glucose metabolism
in STZ diabetic mice. WP supplementation improves the
behavior of diabetic mice and reduces neuronal damage in
the brain caused by oxidative stress.
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